碧迪医疗主动召回骨髓内血管通路系统针组:因拔出针芯困难存安全隐患

美股速递
Aug 01

碧迪医疗(Becton Dickinson)现正主动召回其旗下部分 Intraosseous(骨髓内)血管通路系统针组产品。此举源于该产品的针芯(Obturator)存在拔出困难的问题,可能对患者安全构成威胁。公司已采取行动,以降低潜在风险,确保临床使用的可靠性与安全性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10